PharmAust Limited announced that Dr Roger Aston will remain Chairman of the Board but will transition into a non-executive role assisting with his 40 years of experience in the pharmaceutical and healthcare industry. Appointment: As Non-Executive Chairman. The appointment commences with effect on 1 September 2023 and continues until terminated in accordance with the agreement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 AUD | -4.00% | -15.79% | +108.70% |
Apr. 23 | Pharmaust CEO Resigns | MT |
Apr. 10 | PharmAust Obtains Approval to Commence Monepantel Extension Study | MT |
1st Jan change | Capi. | |
---|---|---|
+108.70% | 61.83M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PAA Stock
- News PharmAust Limited
- PharmAust Limited Appoints Roger Aston as Non-Executive Chairman, Effective 1 September 2023